Stop infertility and stop the spread of sexually transmitted diseases.
The purpose of the Nebraska Infertility Prevention Plus Project (NIPPP)
is to implement prevention strategies to reduce the complications, especially infertility, caused by Chlamydia trachomatis.
Direct and indirect costs associated with chlamydia infections alone are estimated to be $2.4 billion annually. The CDC and OPA (Office of Population Affairs) estimate that “for every $1 spent on chlamydia prevention $12 can be saved.”
Complications associated with getting women into testing include: cost, access to services, gaining awareness of the women considered at risk, and treatment for partners.
The Nebraska Infertility Prevention Plus Project works with cooperating family planning and health care facilities throughout the state testing 30,000 persons per year for chlamydia and gonorrhea. Currently there are over 100 sites providing testing, treatment, and education.
Most infections, particularly in women, do not cause symptoms, therefore a screening program is necessary to identify those who are infected. There are a large percentage of sexually active at-risk women who have been identified through pelvic exams during routine health care visits.
Patients should fit into a high risk category defined as:
- Women 15-24 years of age;
- All other women or men with one of the following:
- New partner or multiple partners in the last 90 days and/or recent contact to a partner with a STD;
- Clinical signs suggestive of chlamydia infection;
- Injection drug users and their sex partners;
- Persons who exchange sex for money or drugs;
- Sex partners of HIV/AIDS infected persons;
- Men who have unprotected sex with men and;
- Heterosexual persons themselves or whose sex partner have had more than one sex partner since their last STD or HIV test.
Becoming a Test Site
Each site provides dual tests for Chlamydia trachomatis and Neisseria gonorrhea.
These test kits include biohazard shipping bags with pre-paid shipping boxes and access to the Electronic Lab Information Reporting Technology (ELIRT) program with technical assistance available, free of charge, paid by the State of Nebraska.
Approved test sites can request to receive free Azithromycin and Ceftriaxone for Chlamydia trachomatis and Neisseria gonorrhea treatment, as funding allows.
In 1991 the Infertility Act offered dollars to regional public health partners throughout the United States. Region VII, which included Iowa, Kansas, Missouri, and Nebraska was originally called Chlamydia Control Project and its main focus was Chlamydia prevention in young women of child baring ages. The project had a name change, Infertility Prevention Project (IPP), around 1998 – 1999 when gonorrhea testing was added. IPP ensured screening and treatment (if necessary) for Chlamydia trachomatis and Neisseria gonorrhea. The goal being a collaborative effort to prevent and reduce STD related infertility.
In order to achieve this goal, partnerships were created with multiple project areas working together to provide high quality Chlamydia/Gonorrhea screening and treatment services. This resulted in several types of clinics participating in this project such as family planning, STD clinics, student health services, corrections, and some local health departments.
Once IPP was no longer funded in 2012, Nebraska implemented an enhanced version with a few project additions and a new name. NIPPP (Nebraska Infertility Prevention Plus Project) provides testing for both women and men, for ages 10 years and up (with one of the high risk categories listed above), offers self-collecting swabs, treatment, and various test site options (clinical, non-clinical settings, express). The Nebraska Infertility Prevention Plus Project strives to provide flexible testing options for all Nebraskans.
This collaborative effort is sponsored by the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services’ Office of Population Affairs.